Daniel A. Weiser
Impact in
- Neurology top 5%
- Neuroblastoma Research and Treatments
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
Papers in ⓘ
- Neurology 12
- Neuroblastoma Research and Treatments 12
-
- Cancer Genomics and Diagnostics 6
- Cancer, Hypoxia, and Metabolism 4
- Co-authors
- Yaël P. Mossé (2 shared papers)Hannah T. Ryles (1 shared paper)Scott C. Bresler (1 shared paper)Kateryna Krytska (1 shared paper)Marci Laudenslager (1 shared paper)Ravi Radhakrishnan (1 shared paper)Peter J. Huwe (1 shared paper)Wendy B. London (2 shared papers)
- Journals
- Pediatric Blood & Cancer (5 papers)Cancer Research (4 papers)Translational Oncology (3 papers)Journal of Clinical Oncology (2 papers)Sarcoma (2 papers)
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Daniel A. Weiser
33 papers receiving 524 citations
Peers
Comparison fields: 5 of 82
- Neurology 250
- Cancer Research 185
- Oncology 161
- Pulmonary and Respiratory Medicine 144
- Molecular Biology 259
Countries citing papers authored by Daniel A. Weiser
This map shows the geographic impact of Daniel A. Weiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Weiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Weiser more than expected).
Fields of papers citing papers by Daniel A. Weiser
This network shows the impact of papers produced by Daniel A. Weiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Weiser. The network helps show where Daniel A. Weiser may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel A. Weiser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 252 | |
| 2 | 2019 | 42 | |
| 3 | 2018 | 37 | |
| 4 | 2013 | 31 | |
| 5 | 2018 | 24 | |
| 6 | 2021 | 20 | |
| 7 | 2020 | 17 | |
| 8 | 2022 | 15 | |
| 9 | 2018 | 13 | |
| 10 | 2020 | 13 | |
| 11 | 2011 | 11 | |
| 12 | 2015 | 6 | |
| 13 | 2019 | 6 | |
| 14 | 2018 | 5 | |
| 15 | 2021 | 5 | |
| 16 | 2021 | 4 | |
| 17 | 2020 | 4 | |
| 18 | 2022 | 2 | |
| 19 | 2020 | 2 | |
| 20 | 2021 | 2 |
About Daniel A. Weiser
Daniel A. Weiser is a scholar working on Neurology, Cancer Research, Pulmonary and Respiratory Medicine, Developmental Neuroscience and Rheumatology, having authored 35 papers that have together received 529 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (12 papers), Sarcoma Diagnosis and Treatment (8 papers), Cancer Genomics and Diagnostics (6 papers), Cancer, Hypoxia, and Metabolism (4 papers), Childhood Cancer Survivors' Quality of Life (3 papers), Cancer Treatment and Pharmacology (2 papers), Nuclear Structure and Function (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Neurology (250 citations), Cancer Research (185 citations), Oncology (161 citations), Pulmonary and Respiratory Medicine (144 citations) and Molecular Biology (259 citations). Daniel A. Weiser has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Yaël P. Mossé, Hannah T. Ryles, Scott C. Bresler, Kateryna Krytska, Marci Laudenslager, Ravi Radhakrishnan, Peter J. Huwe, Wendy B. London, Mark A. Lemmon and Michael D. Hogarty. Their work appears in journals such as Pediatric Blood & Cancer, Cancer Research, Translational Oncology, Journal of Clinical Oncology and Sarcoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.